Who are Polyhexamethylene biguanide's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): .02% Chlorohexidine Gluconate, Chlorhexidine Topical Cream, Chlorhexidine 0.2%, Corsodyl, Chlorhexidine Lavage Solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/polyhexamethylene-biguanide.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Polyhexamethylene biguanide — Competitive Intelligence Brief

Polyhexamethylene biguanide (Polyhexamethylene biguanide) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimicrobial/Antiseptic agent. Area: Dental/Oral Care.

marketed Antimicrobial/Antiseptic agent Dental/Oral Care Small molecule Live · refreshed every 30 min

Target snapshot

Polyhexamethylene biguanide (Polyhexamethylene biguanide) — Altamash Institute of Dental Medicine. Polyhexamethylene biguanide is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and inhibits microbial growth.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Polyhexamethylene biguanide TARGET	Polyhexamethylene biguanide	Altamash Institute of Dental Medicine	marketed	Antimicrobial/Antiseptic agent
.02% Chlorohexidine Gluconate	.02% Chlorohexidine Gluconate	Riyadh Colleges of Dentistry and Pharmacy	marketed	Antimicrobial/Antiseptic agent	Bacterial cell membrane and proteins
Chlorhexidine Topical Cream	Chlorhexidine Topical Cream	Sheikh Zayed Federal Postgraduate Medical Institute	marketed	Antimicrobial/Antiseptic agent
Chlorhexidine 0.2%, Corsodyl	Chlorhexidine 0.2%, Corsodyl	University of Oslo	marketed	Antimicrobial/Antiseptic agent
Chlorhexidine Lavage Solution	Chlorhexidine Lavage Solution	Hamilton Health Sciences Corporation	phase 3	Antimicrobial/Antiseptic agent	Bacterial cell membrane and proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimicrobial/Antiseptic agent class)

Altamash Institute of Dental Medicine · 1 drug in this class
Hamilton Health Sciences Corporation · 1 drug in this class
Riyadh Colleges of Dentistry and Pharmacy · 1 drug in this class
Sheikh Zayed Federal Postgraduate Medical Institute · 1 drug in this class
University of Oslo · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Polyhexamethylene biguanide — Competitive Intelligence Brief. https://druglandscape.com/ci/polyhexamethylene-biguanide. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab